Ligand (LGND) Breakout! | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Ligand (LGND) Breakout!

An SI Board Since September 1996

Posts	SubjectMarks	Bans	Symbol
32384	154	0	LGND

Emcee: Henry Niman	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
30034	The conversions are not easy because the psoriasis trial describes dosing in mg	Henry Niman	-	1/9/2000
30033	Henry, I know there is monthly data on individual drug sales #'s. Is there	Arthur Radley	-	1/9/2000
30032	Interim breast cancer data would be great news and since it is open label.....G	Arthur Radley	-	1/9/2000
30031	I think that LGND is really shooting for profitability this year. Last year th	Henry Niman	-	1/9/2000
30030	henry, do the doses required to treat psoriasis cause any side effects?	Skeeter Bug	-	1/9/2000
30029	LGND has presented at H&Q every year ever since they went public at the end	Henry Niman	-	1/9/2000
30028	As it relates to LGND, what are the possible news items that we might get out o	Arthur Radley	-	1/9/2000
30027	Not sure if it was there when I looked a couple of weeks ago (almost certain it	Henry Niman	-	1/9/2000
30026	More on CTCL and treatment is at lymphomafocus.org Lots on ONTAK and Targretin	Henry Niman	-	1/9/2000
30025	Skeeter, mentioning the FDA and accountability in the same sentence is problema	Torben Noerup Nielsen	-	1/9/2000
30024	The last patent in the area issued in 1998 164.195.100.11	Henry Niman	-	1/9/2000
30023	Henry, Thanks forthe info. I wouldn't worry about the dissenting votes.	psh	-	1/9/2000
30022	Tazarotene (Tazarac)is specific for RAR beta and gamma : pharminfo.com Targreti	Henry Niman	-	1/9/2000
30021	More on Tazarotene: Tazarotene Combinations Helpful in Psoriasis Sherry Bosch	Henry Niman	-	1/9/2000
30020	In addition to Soriatane, Tazarac (Tazarotene) has also been approved for psori	Henry Niman	-	1/9/2000
30019	After reading through the FDA transcript, I think that virtually any vote was p	Henry Niman	-	1/9/2000
30018	henry, when can we expect human breast cancer data for targretin? what about p	Skeeter Bug	-	1/9/2000
30017	t, is there any accountability? could these clowns vote down a cancer cure and	Skeeter Bug	-	1/9/2000
30016	Speaking of getting the word out, maybe we should start with sobrien@marketwatc	Henry Niman	-	1/9/2000
30015	Here's some of the FDA transcript on wording for Soriatane (with regard to	Henry Niman	-	1/9/2000
30014	Roche says that in the US there are 6 million with psoriasis and it looks like	Henry Niman	-	1/9/2000
30013	Andreas, I should file my taxes in Europe then :-) In theory I could since I s	Torben Noerup Nielsen	-	1/9/2000
30012	Henry: I have been trying to figure out how much sales were possible for psoria	Sleepman	-	1/9/2000
30011	Here's more on the soft gel tablets: rpscherer.com	Henry Niman	-	1/9/2000
30010	Although the therapies were approved, they were not approved for CTCL. The tes	Henry Niman	-	1/9/2000

Go to reply# or date (mm/dd/yy):